Your browser doesn't support javascript.
loading
Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network.
Yang, Jiannan; Li, Zhen; Wu, William Ka Kei; Yu, Shi; Xu, Zhongzhi; Chu, Qian; Zhang, Qingpeng.
Afiliación
  • Yang J; School of Data Science, City University of Hong Kong, Hong Kong SAR, China.
  • Li Z; Department of Radiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Wu WKK; Department of Anaesthesia and Intensive Care, Chinese University of Hong Kong, Hong Kong SAR, China.
  • Yu S; The USC Norris Center for Cancer Drug Development, University of Southern California, Los Angeles, CA, USA.
  • Xu Z; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Chu Q; School of Data Science, City University of Hong Kong, Hong Kong SAR, China.
  • Zhang Q; Department of Thoracic Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Brief Bioinform ; 23(6)2022 11 19.
Article en En | MEDLINE | ID: mdl-36347526
ABSTRACT
The discovery and repurposing of drugs require a deep understanding of the mechanism of drug action (MODA). Existing computational methods mainly model MODA with the protein-protein interaction (PPI) network. However, the molecular interactions of drugs in the human body are far beyond PPIs. Additionally, the lack of interpretability of these models hinders their practicability. We propose an interpretable deep learning-based path-reasoning framework (iDPath) for drug discovery and repurposing by capturing MODA on by far the most comprehensive multilayer biological network consisting of the complex high-dimensional molecular interactions between genes, proteins and chemicals. Experiments show that iDPath outperforms state-of-the-art machine learning methods on a general drug repurposing task. Further investigations demonstrate that iDPath can identify explicit critical paths that are consistent with clinical evidence. To demonstrate the practical value of iDPath, we apply it to the identification of potential drugs for treating prostate cancer and hypertension. Results show that iDPath can discover new FDA-approved drugs. This research provides a novel interpretable artificial intelligence perspective on drug discovery.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Reposicionamiento de Medicamentos / Aprendizaje Profundo Límite: Humans Idioma: En Revista: Brief Bioinform Asunto de la revista: BIOLOGIA / INFORMATICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Reposicionamiento de Medicamentos / Aprendizaje Profundo Límite: Humans Idioma: En Revista: Brief Bioinform Asunto de la revista: BIOLOGIA / INFORMATICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: China